Dr. Michele Carbone, MD, PhD

Director, Thoracic Oncology

University of Hawaii Cancer Center

Honolulu, HI

  • Professor of Pathology

Dr. Michele Carbone is among the leading authorities in mesothelioma bap1 gene mutations whose work and published research informs MesoWatch's medical coverage. This page collects publicly available information about their role, institutional affiliations, and contributions to the field.

Areas of Expertise

  • BAP1 Gene Mutations
  • Mesothelioma Genetics
  • Erionite Research
  • L-BAM Discovery

Notable Contributions

  • Discovered BAP1 mutation link to mesothelioma
  • Identified L-BAM as treatable subtype
  • AACR-Landon Innovator Award
  • Knight of Republic of Italy

Public Profile and Verification

The following links lead to publicly available institutional and academic profiles for Dr. Michele Carbone:

MesoWatch Coverage Areas Informed by This Expertise

Disclosure

MesoWatch is an independent journalism organization. The expert authorities profiled here are not employees, paid consultants, or contracted reviewers of MesoWatch. Their inclusion reflects the body of public research and clinical leadership that shapes the standard of care in mesothelioma. Where MesoWatch articles cite or build on the published work of these authorities, the underlying primary source (peer-reviewed publication, institutional press release, or clinical trial record) is linked in the article's Sources section.

For questions about how an expert is referenced, contact [email protected].